Condition
T-Cell Leukemia/Lymphoma, Adult clinical trials and research
As of November 12, 2026, Find a Trial lists 2 T-Cell Leukemia/Lymphoma, Adult clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Preventing Adult T-cell Leukemia/Lymphoma in People with HTLV-1
This study is testing if a new drug called mogamulizumab can help prevent adult T-cell leukemia/lymphoma in adults who are infected with the HTLV-1 virus and are at higher risk for this cancer.
-
New treatment approach for T-cell cancers
This study is testing a new way to treat T-cell cancers by combining different drugs to see if they can help get rid of cancerous T cells in patients who haven't responded to other treatments.
Related topics
Quick answers
How many T-Cell Leukemia/Lymphoma, Adult clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.